Inhibition of Microtubules and Cell Cycle Arrest by a New l-Deaza-7,8-dihydropteridine Antitumor Drug, CI 980, and by Its Chiral Isomer, NSC 613863

Cancer Research

Volumn 54, Issue 1, 1994, Pages 75-84

  de Ines, Concepcion ^a,b,c   Leynadier, Daniel ^a,b,c   Barasoain, Isabel ^a,b,c   Peyrot, Vincent ^a,b,c   Garcia, Patrick ^a,b,c   Briand, Claudette ^a,b,c   Rener, Gregory A ^a,b,c   Temple, Carroll ^a,b,c  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b AIX MARSEILLE UNIVERSITY   (France)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 1,2 DIHYDRO 2 METHYL 3 PHENYLPYRIDO[3,4 B]PYRAZINE 7 CARBAMIC ACID ETHYL ESTER; COLCHICINE; MICROTUBULE PROTEIN; MIVOBULIN ISETHIONATE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE PHASE; CYTOSKELETON; DNA DETERMINATION; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LEUKEMIA; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; MULTIDRUG RESISTANCE; POLYMERIZATION; PRIORITY JOURNAL; STOICHIOMETRY;

ANIMAL; ANTINEOPLASTIC AGENTS; CARBAMATES; CELL CYCLE; CELL LINE; HUMAN; LEUKEMIA, MONOCYTIC, CHRONIC; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MICROTUBULE PROTEINS; MICROTUBULES; PYRAZINES; PYRIDINES; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028044792     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Elliott, R.D. Temple, C. Jr. and Montgomery, J.A. Potential folic acid antagonists. III. Deaza analogs of methotrexate. III. 1-and 3-Deaza analogues of 2, 4-diamino-6-((iV-methylanilino)methyl)pteridine. J. Org. Chem. 33: 533-536, 1968.
2. Temple, C. Jr. Wheeler, G.P. Elliot, R.D. Rose, J.D. Kussner, C.L. Comber, R.N. and Montgomery, J.A. New anticancer agents: synthesis of 1, 2-dihydropyrido-[3, 4-fc]pyrazines (l-deaza-7, 8-dihydropteridines). J. Med. Chem. 25: 1045-1050, 1982.
3. Wheeler, G.P. Bowdon, B.J. Werline, J.A. Adamson, D.J. and Temple, C.G. Jr. Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-l, 2-dihydro-3-((JV-methyllanilino)methyl)-pyrido[3, 4-fc]pyrazin-7-yl-car-bamate (NSC 181928). Cancer Res. 42: 791-798, 1982.
4. Bowdon, B.J. Waud, W.R. Wheeler, G.P. Hain, R. Dansby, L. and Temple, C. Jr. Comparision of l, 2-dihydropyrido[3, 4-fc]pyrazines (l-deaza-7, 8-dihydropteridines) with several other inhibitors of mitosis. Cancer Res. 47: 1621-1626, 1987.
5. Griswold, D.P. Jr. Temple, C.G. Jr. Trader, M.W. Leopold, W.R. Ill, Laster, W.R. Jr. and Dykes, D.J. Antitumor activity of a novel l, 2-dihydropyrido[3, 4-b]-pyrazine in preclinical drug-sensitive and resistant tumors. Proc. Am. Assoc. Cancer Res. 27: 306, 1986.
6. Waud, W.R. Leopold, W R. Elliot, W.L. Dykes, D.J. Laster, W.R. Jr. Temple, C.G. Jr. Harrison, S.D. Jr. and Griswold, D.P. Jr. Antitumor activity of ethyl 5-amino-l, 2-dihydro-2-methyI-3-phenylpyrido[3, 4-fe]pyrazin-7-ylcarbamate, 2-hy-droxyethanesulfonate, hydrate (NSC 370147) against selected tumor systems in culture and in mice. Cancer Res. 50: 3239-3244, 1990.
7. Waud, W.R. Bowdon, B.J. Temple, C.J. Jr. Harrison, S.D. Jr. and Griswold, D.P. Jr. Comparative antitumor activity and mechanistic studies of the S- and R-enantiomers of a novel l, 2-dihydropyrido[3, 4-fc]pyrazine. Proc. Am. Assoc. Cancer Res. 30: 565, 1989.
8. Temple, C. Jr. and Rener, G.A. New anticancer agents: chiral isomers of ethyl 5-amino-l, 2-dihydro-2-methyl-3-phenylpyrido[3, 4-ft)pyrazine-7-carbamate. J. Med. Chem. 32: 2089-2092, 1989.
9. Temple, C. Jr. and Rener, G.A. Antimitotic agents. Chiral isomers of ethyl-(5-amino-l, 2-dihydro-3-(4-hydroxiphenyl)-2-methylpyrido[3, 4-fc]pyrazin-7-yl)-carbamate. J. Med. Chem. 35: 988-993, 1992.
10. Hook, K.E. Przybrnowski, S.A. and Leopold, W.R. Cytotoxicity and uptake of CI-980 and its R-enantiomer. Proc. Am. Assoc. Cane. Res. 33: All, 1992.
11. Leynadier, D. Peyrot, V. Briand, C. Barasoain, I. de Ines, C. Andreu, J.M. Temple, C.G. Jr. and Rener, G.A. Action of a deazapteridine on microtubular system. Effect of chiralty. Proc. Am. Assoc. Cancer Res. 33: 405, 1992.
12. Leopold, W R. Elliot, W L. Prysbranowsky, S.A. and Wand, R.A. In vivo evaluation of the potential for therapeutic synergy between CI 980 and standard chemotherapeutic agents. Proc. Am. Assoc. Cancer Res. 34: 296, 1993.
13. Yeh, H.J.C. Chrzanowska, M. and Brossi, A. The importance of the phenyl-tropolone “aS” configuration in colchicine's binding to tubulin. FEBS Lett. 229: 82-36, 1988.
14. Kelleher, J.K. Tubulin binding affinities of podophyllotoxin and colchicine analogs. Mol. Pharmacol, 13: 232-241, 1977.
15. Leynadier, D. Peyrot, V. Sarrazin, M. Briand, C. Andreu, J.M. Renner, G.A. and Temple, C. Tubulin binding of two l-deaza-7, 8-dihydropteridines with different biological properties: enantiomers NSC 613862 (S)-(-) and NSC 613863 (R)-(+). Biochemistry, 32: 10675-10682, 1993.
16. Fitzgerald, T J. Molecular features of colchicine associated with antimitotic activity and inhibition of tubulin polymerization. Biochem. Pharmacol, 25: 1383-1387, 1976.
17. Andreu, J.M. Gorbunoff, M.J. Lee, J.C. and Timasheff, S.N. Interaction of tubulin with bifunctional colchicine analogues: an equilibrium study. Biochemistry, 23: 1742-1752, 1984.
18. Shelanski, M.L. Gaskin, F. and Cantor, C.R. Microtubule assembly in the absence of added nucleotides. Proc. Natl. Acad. Sci. USA, 70: 765-768, 1973.
19. Peyrot, V. Briand, C. and Andreu, J.M. C-terminal cleavage of tubulin by subtilisin enhances ring formation. Arch. Biochem. Biophys, 249: 611-615, 1990.
20. Weisenberg, R.G. Borisy, G.G. and Taylor, E. W The colchicine-binding protein of mammalian brain and its relation to microtubules. Biochemistry, 7: 4466-4479, 1968.
21. Lee, J.C. Frigon, R.P. and Timasheff, S.N. The chemical characterization of calf brain microtubule protein subunits. J. Biol. Chem, 248: 7253-7262, 1973.
22. Andreu, J.M. and Timasheff, S.N. Tubulin bound to colchicine forms polymers different from microtubules. Proc. Natl. Acad. Sci. USA, 79: 6753-6756, 1982.
23. Bradford, M. A rapid method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem, 72: 248-254, 1976.
24. Arevalo, M.A. Nieto, J.M. Andreu, D. and Andreu, J.M. Tubulin assembly probed with antibodies to synthetic peptides. J. Mol. Biol, 214: 105-120, 1990.
25. Nieto, J.M. Estudio del ensamblaje de microtubules en celulas de mamifero, Doctoral thesis, University of Madrid, 1989.
26. Mollinedo, F. Burgaleta, C. Velasco, G. Arroyo, A.G. Acevedo, A. and Barasoain, I. Enhancement of human neutrophil functions by a monoclonal antibody directed against a 19 KDa antigen. J. Immunol. 149: 323-330, 1992.
27. Crissman, H.A. and Steinkamp, J.A. Rapid simultaneous measurement of DNA, protein and cell volume in single cells from large mammalian cell populations. J. Cell Biol, 59: 766-771, 1973.
28. David-Pfeuty, T. Simon, C. and Pantaloni, D. Effect of antimitotic drugs on tubulin GTPase activity and self assembly. J. Biol. Chem. 254: 11696-11702, 1979.
29. Andreu, J.M. and Timasheff, S.N. Conformational states of tubulin liganded to colchicine, tropolone methyl ether and podophyllotoxin. Biochemistry, 21: 6465-6476, 1982.
30. Saltarelli, D. and Pantaloni, D. Polymerization of tubulin-colchicine complex and guanosine 5′-triphosphate hydrolysis. Biochemistry, 21: 2996-3006, 1982.
31. Andreu, J.M. Wagenknecht, T. and Timasheff, S.N. Polymerization of the tubulin-colchicine complex: relation to microtubule assembly. Biochemistry, 22: 1556-1566, 1983.
32. Olmsted, J.B. and Borisy, G.G. Microtubules. Annu. Rev. Biochem. 42: 507-540, 1973.
33. Loike, J.D. Brewer, C.R. Sternlicht, H. Gensler, W.J. and Horwitz, S.B. A structure activity study of the inhibition of microtubule assembly in vitro by podo-phylotoxin and its congeners. Cancer Res. 58: 2688-2693, 1978.
34. Owellen, R.J. Hartke, C.A. Dickerson, R.M. and Hains, F.O. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class. Cancer Res. 36: 1499-1502, 1976.
35. Peyrot, V. Leynadier, D. Sarrazin, M. Briand, C. Rodriguez, A. Nieto, J.M. and Andreu, J.M. Interaction of tubulin and cellular microtubules with the new antitumor drug MDL 27048. J. Biol. Chem. 264: 21296-21301, 1989.
36. Medrano, F.J. Andreu, J.M. Gorbunoff, M.J. and Timasheff, S.N. Roles of colchicine rings B and C in the binding process to tubulin. Biochemistry, 28: 5589-5599, 1989.
37. Andreu, J.M. Gorbunoff, M.J. Medrano, F.J. Rossi, M. and Timasheff, S.N. Mechanism of colchicine binding to tubulin: tolerance of substituents in ring C of biphenyl analogues. Biochemistry, 30: 3777-3780, 1991.
38. Diez, J.C. Avila, J. Nieto, J.M. and Andreu, J.M. Reversible inhibition of microtubules and cell growth by the bicyclic colchicine analogue MTC. Cell Motil. Cytoskeleton, 7: 178-186, 1987.
39. De Brabander, M. Geuens, G. Nuydens, R. Willebrords, R. and De Mey, J. Microtubule stability and assembly in living cells: the influence of metabolic inhibitors, taxol and pH. Cold Spring Harbor Symp. Quant. Biol. 46: 227-240, 1981.
40. De Brabander, M.J. Van de Veire, R.M.L. Aerts, F.E.M. Borgers, M. and Janssen P.A.J. The effects of methyl-(5-(2-thienylcarbonyl)-l//- benzimidazol-2-yl)carba-mate (R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules on mammalian cells cultured “in vitro.” Cancer Res. 36: 905-916, 1976.
41. Osborn, M. and Weber, K. Cytoplasmic microtubules in tissue culture cells appear to grow from an organizing structure towards the plasma membrane. Cell Biol. 3: 867-871, 1976.
42. Jordan, M.A. Thrower, D. and Wilson, L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res. 51: 2212-2222, 1991.
43. Madoc-Jones, H. and Mauro, F. Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells. J. Cell Physiol. 72: 185-195, 1968.
44. Taylor, E.W. The mechanism of colchicine inhibition of mitosis. J. Cell Biol. 25: 145-160, 1965.
45. Zieve, G.W. Turnbull, D. Mullins, J.M. and McIntosh, J.R. Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Exp. Cell Res. 126: 397-405, 1980.
46. Jordan, M.A. Himes, R.H. and Wilson, L. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation “in vitro.” Cancer Res. 45: 2741-2747, 1985.
47. Wheeler, G.P. Bowdon, B.J. Temple, C. Jr. Adamson, D.J. and Webster, J. Biological effects and structure-activity relationships of l, 2-dihydropyrido[3, 4-fc>]-pyrazines. Cancer Res. 43: 3567-3575, 1983.
48. Martin, S.J. and Cotter, T G. Disruption of microtubules induces an endogenous suicide pathway in human leukaemia HL60 cells. Cell Tissue Kinet. 23: 545-559, 1990.
49. Himes, R.H. Kersey, R.N. Heller-Bettinger, I. and Samson, F.E. Action of the Vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res. 36: 3798-3802, 1976.
50. Wilson, L. Jordan, M.A. Morse, A. and Margolis, R.L. Interaction of vinblastine with steady-state microtubules “in vitro.” J. Mol. Biol. 159: 125-149, 1982.